{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:36:04Z","timestamp":1788813364507,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3081,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.ki.5002305","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T12:54:45Z","timestamp":1178715285000},"page":"213-218","source":"Crossref","is-referenced-by-count":77,"title":["Amylin deposition in the kidney of patients with diabetic nephropathy"],"prefix":"10.1016","volume":"72","author":[{"given":"W.","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.P.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002305_bb0010","first-page":"245","article-title":"Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells","volume":"135","author":"Johnson","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5002305_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJM198908243210806","article-title":"Islet amyloid, islet amyloid polypeptide and diabetes mellitus","volume":"321","author":"Johnson","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002305_bb0020","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5002305_bb0025","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jmb.2003.11.048","article-title":"Structural characterization of islet amyloid polypeptide fibrils","volume":"335","author":"Sumner Makin","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1038\/sj.ki.5002305_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"Hoppener","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002305_bb0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/385787a0","article-title":"Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis","volume":"385","author":"Booth","year":"1997","journal-title":"Nature"},{"key":"10.1038\/sj.ki.5002305_bb0040","first-page":"86","article-title":"Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus","volume":"3","author":"Hayden","year":"2002","journal-title":"JOP"},{"key":"10.1038\/sj.ki.5002305_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/bbrc.1997.7465","article-title":"Renal elimination of islet amyloid polypeptide","volume":"239","author":"Leckstrom","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/sj.ki.5002305_bb0050","first-page":"49","article-title":"Amyloidosis of the islets of Langerhans, a restudy of islet hyalin in diabetic and nondiabetic individuals","volume":"38","author":"Ehrlich","year":"1961","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5002305_bb0055","first-page":"151","article-title":"Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes","volume":"9","author":"Clark","year":"1988","journal-title":"Diabetes Res"},{"key":"10.1038\/sj.ki.5002305_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF01219652","article-title":"The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus","volume":"15","author":"Westermark","year":"1978","journal-title":"Diabetologia"},{"key":"10.1038\/sj.ki.5002305_bb0065","first-page":"124","article-title":"\u2018A\u2019 is for amylin and amyloid in Type 2 Diabetes Mellitus","volume":"2","author":"Hayden","year":"2001","journal-title":"JOP"},{"key":"10.1038\/sj.ki.5002305_bb0070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.ASN.0000065100.17349.CA","article-title":"Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetes nephropathy","volume":"14","author":"Wendt","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002305_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","article-title":"Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology","volume":"1537","author":"Jaikaran","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"Part 1","key":"10.1038\/sj.ki.5002305_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj3430053","article-title":"Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet beta-cells","volume":"343","author":"Bai","year":"1999","journal-title":"Biochem J"},{"key":"10.1038\/sj.ki.5002305_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-5793(99)00894-7","article-title":"Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1\/CIP1","volume":"455","author":"Zhang","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1038\/sj.ki.5002305_bb0090","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/db05-1672","article-title":"Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes","volume":"55","author":"Matveyenko","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/sj.ki.5002305_bb0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"10.1038\/sj.ki.5002305_bb0100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0002-9440(10)65360-6","article-title":"Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells","volume":"154","author":"Hiddinga","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5002305_bb0105","first-page":"541","article-title":"Amylin induces apoptosis of cultured human mesangial cells","volume":"11","author":"Peng","year":"2002","journal-title":"Chin J Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002305_bb0110","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","article-title":"The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells","volume":"273","author":"Konarkowska","year":"2006","journal-title":"FEBS J"},{"key":"10.1038\/sj.ki.5002305_bb0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1038\/sj.ki.5002305_bb0120","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1042\/BST0320865","article-title":"Amylin receptors: molecular composition and pharmacology","volume":"32","author":"Hay","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"10.1038\/sj.ki.5002305_bb0125","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1681\/ASN.V1191656","article-title":"Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease","volume":"11","author":"Tanji","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002305_bb0130","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.micinf.2004.08.004","article-title":"RAGE (receptor for advanced glycation end products): a central player in the inflammatory response","volume":"6","author":"Chavakis","year":"2004","journal-title":"Microbes Infect"},{"key":"10.1038\/sj.ki.5002305_bb0135","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/01.RES.0000103862.26506.3D","article-title":"Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond","volume":"93","author":"Yan","year":"2003","journal-title":"Circ Res"},{"issue":"Part 1","key":"10.1038\/sj.ki.5002305_bb0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/01.HYP.30.3.455","article-title":"Increased density of renal amylin binding sites in experimental hypertension","volume":"30","author":"Wookey","year":"1997","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5002305_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/path.1711750214","article-title":"High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment","volume":"175","author":"de Koning","year":"1995","journal-title":"J Pathol"},{"key":"10.1038\/sj.ki.5002305_bb0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/diab.40.3.310","article-title":"Newly identified pancreatic protein islet amyloid polypeptide: what is its relationship to diabetes?","volume":"40","author":"Johnson","year":"1991","journal-title":"Diabetes"},{"key":"10.1038\/sj.ki.5002305_bb0155","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","article-title":"Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins","volume":"269","author":"Yan","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002305_bb0160","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1432-1327.1998.2510208.x","article-title":"Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide","volume":"251","author":"Kapurniotu","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1038\/sj.ki.5002305_bb0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815526203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815526203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T06:57:39Z","timestamp":1628837859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815526203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0085253815526203"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002305","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}